Hyperkalemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or older with stable vital signs, specifically defined as: (1) Body temperature: 36.0°C–38.0°C; (2) Pulse: 50–120 beats/min; (3) Respiratory rate: 10–24 breaths/min; (4) Blood pressure: Systolic blood pressure >=90 mmHg and diastolic blood pressure >=60 mmHg. 2. Willing to participate in the study and sign the informed consent form. 3. Hematocrit (Hct) level between 25% and 60%. 4. Confirmed diagnosis of chronic kidney disease (CKD).
Exclusion criteria
Exclusion criteria: 1. Patients in the unstable phase of acute cardiovascular or cerebrovascular diseases (e.g., acute cerebral infarction, cerebral hemorrhage, or acute coronary syndrome). 2. Patients in the unstable phase of severe acute diabetic complications (e.g., diabetic ketoacidosis or hyperosmolar hyperglycemic coma). 3. Patients currently in the acute kidney injury (AKI) stage. 4. Patients who have started renal replacement therapy. 5. Pregnant or breastfeeding women. 6. Patients currently participating in or who have participated in other clinical trials within the past six months. 7. Patients unable to understand verbal or written instructions, including informed consent content. 8. Patients unable to cooperate with the study procedures. 9. Other conditions deemed unsuitable for participation in this clinical trial by the investigator.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Blood Glucose;Creatinine;Uric Acid;Hemoglobin; | — |
Primary
| Measure | Time frame |
|---|---|
| Blood Potassium;Area under ROC curve;sensitivity;specificity; | — |
Countries
China
Contacts
Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine